Patent Assignment
Reel/Frame 025741/0564
Release of Security Interest
Recorded: 2011-02-03
Pages: 11
Assignor
CREDIT SUISSE AG
Executed: 2011-01-31
Assignee
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
501 FIFTH STREET, BRISTOL, TENNESSEE, 37620
Covered Properties
(50)
Multi-Fractionable Tablet Structure
Patent:
4,215,104 →
Application:
06/024,139 →
Carboxyalkyl Dipeptides
Application:
06/258,484 →
Sustained Release Tablet Containing at Least 95 Percent Theophylline
Patent:
4,465,660 →
Application:
06/451,891 →
Disubstituted Proline Derivatives,
Patent:
4,684,662 →
Application:
06/568,423 →
Racemates of Optically Active Bicyclic Imino-Alpha- Carboxylic Esters
Patent:
4,668,796 →
Application:
06/575,401 →
Process for the Preparation of N-Alkylated Dipeptides and Their Esters
Patent:
4,525,301 →
Application:
06/604,220 →
Sustained Release Tablet Containing at Least 95 Percent Theophylline
Patent:
4,547,358 →
Application:
06/616,982 →
Angiotensin-Coverting Enzyme Inhibitors
Patent:
4,587,258 →
Application:
06/635,390 →
Method for Making -2-Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids
Patent:
4,727,160 →
Application:
06/658,902 →
Method of Resolving Bicyclic Imino-Alpha-Carboxylic Acid Ester Racemates
Patent:
4,659,838 →
Application:
06/681,329 →
Optically Active Bicylic Imino-Alpha-Carboxylic Esters
Patent:
4,822,894 →
Application:
07/023,277 →
Process of Preparing Proline Derivatives
Patent:
4,849,524 →
Application:
07/122,380 →
Derivatives of Bicyclic Aminocarboxylic Acids
Patent:
4,868,307 →
Application:
07/127,953 →
Process for the Preparation of N-Alkylated Dipeptides and Their Esters
Patent:
5,055,591 →
Application:
07/173,024 →
Process for the Preparation of Bicyclic Amino Carboxylic Acids, Intermediates in This Process, and Their Use
Patent:
5,011,940 →
Application:
07/214,457 →
Angiotensin-Converting Enzyme Inhibitors
Patent:
4,831,157 →
Application:
07/250,300 →
A Process for the Preparation of Cis, Endo-2- Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids
Patent:
4,879,403 →
Application:
07/267,753 →
Stabilized Medicinal Substances, a Process for the Preparation Thereof, and Stable Medicinal Formulations
Patent:
5,151,433 →
Application:
07/274,598 →
Cis, Endo-2-Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids, a Process for Their Preparation, Agents Containing These Compounds and Their Use
Patent:
5,061,722 →
Application:
07/296,513 →
Cis, Endo-2-Azabicyclo-(3.3.0)-Octane-5-Carboxylic Acids
Patent:
5,053,519 →
Application:
07/318,519 →
Novel Method of Myocardial Imaging
Patent:
5,070,877 →
Application:
07/330,156 →
Intermediates for Preparing Mono-,Bi-and Tricyclic Amino Acids
Patent:
4,977,260 →
Application:
07/335,443 →
Combination of Angiotensin Converting Enzyme Inhibitors with Potassium Channel Modulators and Use Thereof in Pharmaceuticals
Patent:
4,975,453 →
Application:
07/357,822 →
Combination of Angiotensin-Converting Enzyme Inhibitors with Calcium Antagonists as Well as Their Use in Drugs
Patent:
5,098,910 →
Application:
07/358,427 →
Process for the Preparation of N Octahydropenta (B) Pyrrole Carboxylates
Patent:
5,068,351 →
Application:
07/560,004 →
Process for the Resolution of Racemates of Optically Active Bicyclic Imino-Alpha-Carboxylic Esters
Patent:
5,175,306 →
Application:
07/562,402 →
Method for the Treatment of Cardiac and of Vascular Hypertrophy and Hyperplasia
Patent:
5,231,083 →
Application:
07/564,618 →
Method for the Treatment of Atherosclerosis, Thrombosis, and Peripheral Vessel Disease
Patent:
5,231,080 →
Application:
07/678,187 →
Compounds Having a Cognition Adjuvant Action, Agents Containing Them, and the Use Thereof for the Treatment and Prophylaxis of Cognitive Dysfunctions
Patent:
5,231,084 →
Application:
07/711,719 →
Usle of a Combination of Angiotensin-Converting Enzyme Inhibitor and Calcium Antagonist for the Treatment of Proteinuria
Patent:
5,236,933 →
Application:
07/798,501 →
Pharmaceutical Composition for the Treatment of High Blood Pressure
Patent:
5,256,687 →
Application:
07/979,390 →
Use of a Combination of Angiotensin-Converting Enzyme Inhibitor and Calcium Antagonist for the Treatment of Proteinuria
Patent:
5,366,994 →
Application:
08/057,516 →
Method of Treating Cardiac Insufficiency Using Angiotension- Converting Enzyme Inhibitors
Patent:
5,403,856 →
Application:
08/188,745 →
Stabilized Polymer Film Coated Compounds and Stabilized Formulations in Compressed from Using Same
Patent:
5,442,008 →
Application:
08/194,634 →
Cis, Endo-2-Azabicycloalkane-3-Carboxylic Acid Derivatives
Patent:
5,550,255 →
Application:
08/202,478 →
Preparations Stimulating Nail Growth
Patent:
6,007,798 →
Application:
08/930,562 →
Thiophenes Useful for Modulating the Adenosine Receptor
Patent:
5,939,432 →
Application:
08/959,758 →
N6-Substituted-Adenosine-5'-Uronamides as Adenosine Receptor Modulator
Patent:
6,048,865 →
Application:
09/124,434 →
Pharmaceutical Combination Preparation of an Inhibitor of the Sodium/Hydrogen Exchanger and a Medicament for the Treatment of Cardiovascular Diseases
Application:
09/139,385 →
Allosteric Adenosine Receptor Modulators
Patent:
6,323,214 →
Application:
09/156,077 →
Method of Minimizing Damage to Heart Tissue During Cardiac Surgery and Cardiac Transplantation
Application:
09/300,128 →
Allosteric Adenosine Receptor Modulators
Patent:
6,177,444 →
Application:
09/307,225 →
Allosteric Adenosine Receptor Modulators
Patent:
6,194,449 →
Application:
09/307,286 →
The Use of Adenosine A3 Receptor Antagonists to Inhibit Tumor Growth
Patent:
6,326,390 →
Application:
09/377,271 →
Adenosine a Receptor Modulators
Patent:
6,407,236 →
Application:
09/379,300 →
Diagnostic Uses of 2-Substituted Adenosine Carboxamides
Patent:
6,368,573 →
Application:
09/440,330 →
Adenosine, A3 receptor modulators
Patent:
6,358,964 →
Application:
09/625,583 →
Method for treating hyper-excited sensory nerve functions in humans
Patent:
6,248,774 →
Application:
09/654,994 →
Allosteric Adenosine Receptor Modulators
Method for Treating Pain in Humans
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement
May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest
Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →
Release of Security Interest
Feb 4, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS, INC.
Reel/Frame 025746/0793 →